You just read:

FDA Grants QIDP Designation to LMB for Mino-Lok™, a Novel Antibiotic Lock Therapy in Development to Treat Catheter Related Blood Stream Infection (CRBSI)

News provided by

Leonard Meron Biosciences, Inc. (LMB)

Oct 12, 2015, 05:25 ET